1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on April 21, 2025

AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients
AZN

Benzinga

3 hours ago

AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients

AZN

MT Newswires

4 hours ago

AstraZeneca Says Breast Cancer Combination Therapy Shows Improvement in Progression-Free Survival

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer
AZN

Business Wire

4 hours ago

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
AZN

Bloomberg

4 days ago

Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s

Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?
AZN

Insider Monkey

6 days ago

Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?

Tariff wars to hit popular US-made drugs in China, regulator data shows
AZN

Reuters

6 days ago

Tariff wars to hit popular US-made drugs in China, regulator data shows

Is AstraZeneca (AZN) The Best UK Stock to Buy According to Billionaires?
AZN

Insider Monkey

7 days ago

Is AstraZeneca (AZN) The Best UK Stock to Buy According to Billionaires?

Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now
AZN

Motley Fool

7 days ago

Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now

The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
AZN

Zacks

7 days ago

The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
AZN

Zacks

10 days ago

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
AZN

Pharmaceutical Technology

10 days ago

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
AZN

Zacks

11 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY
AZN

Simply Wall St.

12 days ago

AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY

Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
AZN

Motley Fool

12 days ago

Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today

Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’
AZN

Bloomberg

12 days ago

Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’

3 No-Brainer Growth Stocks to Buy for Less Than $100
AZN

Motley Fool

12 days ago

3 No-Brainer Growth Stocks to Buy for Less Than $100

Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know
AZN

Zacks

13 days ago

Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know

AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy
AZN

Clinical Trials Arena

13 days ago

AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy

AZN

Morningstar Research

14 days ago

Analyst Report: AstraZeneca PLC

AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs
AZN

Zacks

14 days ago

AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs

AZN

Argus Research

14 days ago

Weekly Stock List

EC approves AstraZeneca’s Imfinzi combo for NSCLC
AZN

Pharmaceutical Technology

14 days ago

EC approves AstraZeneca’s Imfinzi combo for NSCLC

AstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi Sankyo
AZN

Simply Wall St.

17 days ago

AstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi Sankyo

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings
AZN

Benzinga

17 days ago

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

AZN

MT Newswires

17 days ago

European Equities Spiral in Friday Trading Amid Global Selloff Sparked by US Tariffs

Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
AZN

Pharmaceutical Technology

17 days ago

Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure
AZN

Zacks

17 days ago

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?
AZN

Simply Wall St.

17 days ago

AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?

AZN

MT Newswires

17 days ago

Astrazeneca Says Imfinzi Approved in Europe for Operable Non-Small Cell Lung Cancer

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs
AZN

The Wall Street Journal

18 days ago

Spirits, Swiss Watches, Sneakers: Global Stock-Market Winners and Losers from Tariffs

AZN

Thomson Reuters StreetEvents

19 days ago

Q4 2024 AIM ImmunoTech Inc Earnings Call

AstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trial
AZN

TipRanks

20 days ago

AstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trial

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication
AZN

Zacks

20 days ago

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial
AZN

Clinical Trials Arena

20 days ago

AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial

FDA approves AstraZeneca’s Imfinzi combo for bladder cancer
AZN

Pharmaceutical Technology

20 days ago

FDA approves AstraZeneca’s Imfinzi combo for bladder cancer

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
AZN

Investor's Business Daily

21 days ago

Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients
AZN

Benzinga

21 days ago

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients

AZN

MT Newswires

21 days ago

AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial

​​AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial
AZN

Business Wire

21 days ago

​​AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer
AZN

Zacks

21 days ago

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Stocks to Watch Monday: Nvidia, Tesla, Moderna, Stellantis
AZN

The Wall Street Journal

21 days ago

Stocks to Watch Monday: Nvidia, Tesla, Moderna, Stellantis

AZN

MT Newswires

21 days ago

Astrazeneca's Imfinzi Approved in US for Treatment of Muscle-Invasive Bladder Cancer

AZN

MT Newswires

21 days ago

Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
AZN

Business Wire

21 days ago

IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?
AZN

Insider Monkey

24 days ago

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds?

U.S. to end funding for child vaccines in developing countries, NY Times reports
AZN

TipRanks

25 days ago

U.S. to end funding for child vaccines in developing countries, NY Times reports

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet
AZN

Zacks

25 days ago

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology
AZN

Pharma Voice

25 days ago

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

AstraZeneca says new results reinforce Tagrisso as backbone therapy
AZN

TipRanks

a month ago

AstraZeneca says new results reinforce Tagrisso as backbone therapy

Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know
AZN

Zacks

a month ago

Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings
AZN

Business Wire

a month ago

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Assemblin to upgrade AstraZeneca’s Gärtuna plant in Sweden
AZN

World Construction Network

a month ago

Assemblin to upgrade AstraZeneca’s Gärtuna plant in Sweden

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
AZN

Zacks

a month ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

AstraZeneca to invest $2.5bn in R&D centre in China
AZN

Pharmaceutical Technology

a month ago

AstraZeneca to invest $2.5bn in R&D centre in China

Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead
AZN

Motley Fool

a month ago

Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside Ahead

AZN

MT Newswires

a month ago

Sector Update: Health Care Stocks Retreat Late Afternoon

AZN

MT Newswires

a month ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

AZN

MT Newswires

a month ago

Sector Update: Health Care

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals
AZN

Zacks

a month ago

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?
AZN

Zacks

a month ago

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?

AstraZeneca to invest £2bn in Beijing amid China investigation
AZN

The Telegraph

a month ago

AstraZeneca to invest £2bn in Beijing amid China investigation

Micron, Johnson & Johnson, AstraZeneca: Top Stocks
AZN

Yahoo Finance Video

a month ago

Micron, Johnson & Johnson, AstraZeneca: Top Stocks

AstraZeneca to Invest $2.5 Billion in China Amid Probes
AZN

The Wall Street Journal

a month ago

AstraZeneca to Invest $2.5 Billion in China Amid Probes

AstraZeneca Invests $2.5 Billion in R&D Center in China
AZN

The Wall Street Journal

a month ago

AstraZeneca Invests $2.5 Billion in R&D Center in China

AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe
AZN

Bloomberg

a month ago

AstraZeneca Invests $2.5 Billion in Beijing Hub Amid Probe

AZN

MT Newswires

a month ago

Update: Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive

AZN

MT Newswires

a month ago

Market Chatter: AstraZeneca to Invest $2.5 Billion in Beijing Despite Recent Detaining of Executive

AZN

Financial Times

a month ago

AstraZeneca to invest $2.5bn in China after scandal

AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals
AZN

Reuters

a month ago

AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals

Here’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)
AZN

Insider Monkey

a month ago

Here’s Why Parnassus Growth Equity Fund Decided to Sell AstraZeneca PLC (AZN)

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
AZN

Zacks

a month ago

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?
AZN

Insider Monkey

a month ago

Is AstraZeneca (AZN) the Best European Stock to Buy According to Billionaires?

AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
AZN

Clinical Trials Arena

a month ago

AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III

AstraZeneca and Alteogen agree on ALT-B4 platform tech
AZN

Pharmaceutical Technology

a month ago

AstraZeneca and Alteogen agree on ALT-B4 platform tech

AZN

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Late Afternoon

AZN

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain Monday Afternoon

AZN

MT Newswires

a month ago

Sector Update: Health Care

AZN

MT Newswires

a month ago

European Equities Rise in Monday Trading; AstraZeneca to Acquire EsoBiotec for Up to $1 Billion

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer
AZN

Zacks

a month ago

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer

AZN

MT Newswires

a month ago

AstraZeneca's Imfinzi Approved by EU for Treatment of Small Cell Lung Cancer

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
AZN

PR Newswire

a month ago

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals

Eventful Monday For AstraZeneca - What's Going On?
AZN

Benzinga

a month ago

Eventful Monday For AstraZeneca - What's Going On?

AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec
AZN

MT Newswires

a month ago

AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec

AZN

MT Newswires

a month ago

AstraZeneca Enters Deal to Acquire Cell Therapy Firm EsoBiotec for Up to $1 Billion

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio
AZN

The Wall Street Journal

a month ago

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy
AZN

Reuters

a month ago

AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition
AZN

GlobeNewswire

a month ago

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

AstraZeneca Stock Scores RS Rating Upgrade
AZN

Investor's Business Daily

a month ago

AstraZeneca Stock Scores RS Rating Upgrade

AZN

Morningstar Research

a month ago

Analyst Report: AstraZeneca PLC

INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants
AZN

Clinical Trials Arena

a month ago

INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participants

AstraZeneca director says AI must be a “thought partner” in drug discovery
AZN

Pharmaceutical Technology

a month ago

AstraZeneca director says AI must be a “thought partner” in drug discovery

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer
AZN

Business Wire

a month ago

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
AZN

Investor's Business Daily

a month ago

AstraZeneca Stock Nears Buy Point After Long Run In Declining Market

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?
AZN

Zacks

a month ago

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
AZN

Zacks

a month ago

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
AZN

Investor's Business Daily

a month ago

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion

AZN

Argus Research

a month ago

Analyst Report: AstraZeneca PLC

AZN

Argus Research

a month ago

Market Update: CME, LHX, NYT, SHW, SJM, AZN

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe
AZN

Zacks

a month ago

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy
AZN

Pharmaceutical Technology

a month ago

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy

Share on Social Networks: